Streetbeat News

Stock Prices

EBS

Emergent Biosolutions shares surged following the announcement of operational changes aimed at stabilizing its financial position, alongside the release of its Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 9:13 pm

CTVA

Corteva (NYSE:CTVA) reported Q1 2024 adjusted earnings per share of $0.89, surpassing the consensus estimate of $0.84. However, its quarterly sales of $4.492 billion fell short of the expected $4.646 billion, marking an 8.03% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 9:12 pm

CLMB

Climb Global Solutions (NASDAQ:CLMB) reported Q1 2024 earnings of $0.60 per share, missing the $0.75 estimate, and sales of $92.422M, below the $105.442M estimate. This represents a decrease in earnings and an increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 9:11 pm

MYRG

MYR Group reported Q1 2024 earnings of $1.12 per share, missing the $1.19 estimate, and sales of $815.562M, below the $854.134M estimate. This represents an 18.84% decrease in earnings and a 0.49% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 9:10 pm

RSI

Rush Street Interactive (NYSE:RSI) reported Q1 earnings of $0.03 per share, surpassing the $(0.02) estimate, marking a 250% beat and a 137.5% increase from last year's $(0.08) per share loss. Sales reached $217.43M, exceeding the $196.88M estimate by 10.44% and showing a 33.92% increase from last year's $162.36M.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 9:09 pm

ASPN

Aspen Aerogels (NYSE:ASPN) reported Q1 EPS of $(0.02), surpassing the $(0.11) estimate, and sales of $94.50M, exceeding the $75.00M estimate. This represents significant improvements over the previous year, with a 91.67% decrease in losses and a 107.30% increase in sales.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 9:08 pm

JAZZ

Jazz Pharmaceuticals reported Q1 2024 adjusted EPS of $2.68, missing the $4.18 estimate, and sales of $901.983M, missing the $953.896M estimate. This represents a 1.03% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 9:08 pm

BV

BrightView Holdings has revised its FY24 revenue forecast downwards from the previous range of $2.825B-$2.975B to a new range of $2.74B-$2.80B, which is below the estimated $2.844B.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 9:08 pm

AMWL

American Well (AMWL) reported Q1 2024 GAAP EPS of $(0.25), missing the $(0.19) estimate, with sales of $59.522M also missing the $60.524M estimate, marking a 7.00% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 9:07 pm

EBS

Emergent BioSolutions is implementing strategic operational changes to stabilize its financial position, which includes reducing its workforce by approximately 300 employees across all areas of the company.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 9:06 pm